Coherus Oncology Inc. (CHRS) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Coherus Oncology Inc.

    NASDAQ: CHRS · Real-Time Price · USD
    1.50
    0.05 (3.45%)
    At close: Sep 26, 2025, 3:59 PM
    1.49
    -0.67%
    After-hours: Sep 26, 2025, 06:58 PM EDT

    Coherus Oncology Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 266.96M 257.24M 211.04M 326.55M
    Cost of Revenue
    		 117.55M 158.99M 70.08M 57.59M
    Gross Profit
    		 149.41M 98.25M 140.96M 268.96M
    Operating Income
    		 -111.67M -203.2M -256.88M -263.86M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 28.51M -238.27M -291.75M -287.1M
    Net Income
    		 28.51M -237.89M -291.75M -287.1M
    Selling & General & Admin
    		 167.74M 185.62M 198.48M 169.71M
    Research & Development
    		 93.34M 109.44M 199.36M 363.11M
    Other Expenses
    		 n/a 6.4M n/a n/a
    Operating Expenses
    		 261.07M 301.45M 397.84M 532.82M
    Interest Expense
    		 27.16M 40.54M 32.47M 22.96M
    Selling & Marketing Expenses
    		 10.9M 10.9M 10.5M 8.7M
    Cost & Expenses
    		 378.63M 460.44M 467.92M 590.41M
    Income Tax Expense
    		 n/a -380K 34.87M 19.22M
    Shares Outstanding (Basic)
    		 114.55M 94.16M 77.63M 75.45M
    Shares Outstanding (Diluted)
    		 114.83M 94.16M 77.63M 75.45M
    EPS (Basic)
    		 0.25 -2.53 -3.76 -3.81
    EPS (Diluted)
    		 0.25 -2.53 -3.76 -3.81
    EBITDA
    		 60.94M -193.94M -255.58M -260.69M
    EBIT
    		 55.66M -197.73M -259.28M -264.14M
    Depreciation & Amortization
    		 5.28M 3.79M 3.7M 3.45M

    Add to Watchlist